In: cancer therapies
María José Alonso’s Lab participates in the ONCOLIBERIX Consortium for the development of oncological drugs of marine origin
December 2, 2022This consortium, led by PharmaMar, brings together four leading research groups in nanotechnology and oncology.
Read More